Prolintane is a central nervous system (CNS) stimulant and norepinephrine-dopamine reuptake inhibitor (NDRI) developed in the 1950s. It is chemically related to amphetamine and shares structural similarities with drugs like pyrovalerone, MDPV, and propylhexedrine.
Prolintane acts by inhibiting the reuptake of norepinephrine and dopamine, leading to increased concentrations of these neurotransmitters in the synaptic cleft, which enhances alertness, energy, and concentration.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Prolintan, Phenylpyrrolidinopentane |
|---|---|
| IUPAC Name | 1-(1-phenylpentan-2-yl)pyrrolidine |
| CAS | 493-92-5 |
| Molecular Weight | 217.35 |
| Molecular Formula | C15H23N |
| SMILES | CCCC(CC1=CC=CC=C1)N2CCCC2 |